Neuroinflammation and the genetics of Alzheimer’s disease: The search for a pro-inflammatory phenotype
- 1 June 2001
- journal article
- review article
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 13 (3) , 163-170
- https://doi.org/10.1007/bf03351475
Abstract
The role of interleukin 1 (IL-1) and interleukin 6 (IL-6) in the pathogenesis of Alzheimer’s disease (AD) is reviewed within the framework of “inflammaging”, i.e., the characteristic chronic pro-inflammatory status which develops in old age, and neuroinflammation, i.e., the peculiar inflammatory process which is present in the brain of AD patients. In particular, the data suggesting that several IL-1 and IL-6 gene polymorphisms can contribute to the risk of developing AD are reviewed. The possibility as well as the difficulty in identifying a pro-inflammatory phenotype, and its importance for the prevention, diagnosis and therapy of AD and other age-related pathologies are discussed.Keywords
This publication has 42 references indexed in Scilit:
- Appearance of biomarkers of in vitro ageing after successive stimulation of WI‐38 fibroblasts with IL‐1α and TNF‐α: senescence associated β‐galactosidase activity and morphotype transitionJournal of Anatomy, 2000
- Association of an interleukin 1α polymorphism with Alzheimer’s diseaseNeurology, 2000
- Alzheimer's disease: An inflammatory disease?Neurobiology of Aging, 2000
- Age-Associated Increased Interleukin-6 Gene Expression, Late-Life Diseases, and FrailtyAnnual Review of Medicine, 2000
- A Role for apoE in Regulating the Levels of α-1-Antichymotrypsin in the Aging Mouse Brain and in Alzheimer's DiseaseThe American Journal of Pathology, 1999
- Associations of elevated Interleukin-6 and C-Reactive protein levels with mortality in the elderly∗∗Access the “Journal Club” discussion of this paper at http:/www.elsevier.com/locate/ajmselect/The American Journal of Medicine, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.Journal of Clinical Investigation, 1998
- Increased cytokine production in mononuclear cells of healthy elderly peopleEuropean Journal of Immunology, 1993
- Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease corticesFEBS Letters, 1991